Position in ABBV
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$3,513,333
-$2,671 QoQ
Shares Held
16,154
+5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Leo Wealth, LLC holds $70,294,241 across 12 Drug Manufacturers - General names. ABBV ranks #4 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
171,116 | $41,827,595 | |
| 2 | BIIB |
Biogen Inc.
|
22,737 | $4,168,374 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
65,938 | $3,999,139 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
16,154 | $3,513,333 | |
| 5 | LLY |
ELI LILLY & Co
|
3,398 | $3,125,378 | |
| 6 | MRK |
Merck & Co., Inc.
|
24,749 | $2,977,057 | |
| 7 | PFE |
Pfizer Inc
|
104,084 | $2,922,678 | |
| 8 | NVS |
Novartis AG
|
15,866 | $2,423,531 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,513,333 | 16,154 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,516,004 | 15,388 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,928,749 | 12,649 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,190,557 | 22,576 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $4,245,503 | 20,263 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,759,954 | 21,159 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $4,389,585 | 22,228 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $3,564,700 | 20,783 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,932,445 | 10,612 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,842,149 | 18,340 | Shares | Sole | 2024-03-14 | |
| No filing history on record for this holder in this stock. | ||||||